In meningitis outbreak, Medicare likely paid

Medicare is coming under scrutiny in the meningitis outbreak that has rekindled doubts about the safety of the nation's drug supply. The health insurance program said compound drugs were a risk, but did not use its power to block payment. (Oct. 19)